Source:http://linkedlifedata.com/resource/pubmed/id/16402537
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2006-1-11
|
pubmed:abstractText |
The topical treatment of psoriasis benefits from the alternate use of dermocorticosteroids and vitamin D3 analogues. A new galenic formulation allows to combine them in a single application. Dovobet (LEO Pharma) ointment is the association of calcipotriol 50 microg/g with betamethasone dipoprionate 0.5 mg/g. This formulation boosts the therapeutic activity of calcipotriol. It also decreases the irritative inflammatory reaction due to calcipotriol without increasing the atrophogenic risk of the dermocorticoid.
|
pubmed:language |
fre
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Nov
|
pubmed:issn |
0370-629X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
60
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
893-5
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16402537-Administration, Topical,
pubmed-meshheading:16402537-Betamethasone,
pubmed-meshheading:16402537-Calcitriol,
pubmed-meshheading:16402537-Drug Therapy, Combination,
pubmed-meshheading:16402537-Humans,
pubmed-meshheading:16402537-Inflammation,
pubmed-meshheading:16402537-Psoriasis
|
pubmed:year |
2005
|
pubmed:articleTitle |
[The calcipotriol-betamethasone dipropionate association].
|
pubmed:affiliation |
CHU du Sart Tilman, Service de Dermatopathologie, Liège.
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|